Yi Ba

ORCID: 0009-0002-9631-5228 · 1 paper in corpus
2025
·doi:10.1101/2025.09.01.673435

BRAF mutant colorectal cancer (CRC) is highly aggressive and often resistant to traditional therapies, presenting a significant challenge in cancer immunotherapy. Understanding the tumor microenvironment (TME) and identifying novel immune c…